| SpectraBase Spectrum ID |
8K2Vrd9slQu |
| Name |
EAM-2201 |
| CAS Registry Number |
1364933-60-7 |
| Classification |
Aroylindole cannabinoid designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
387.199842623 u |
| Formula |
C26H26FNO |
| InChI |
InChI=1S/C26H26FNO/c1-2-19-14-15-23(21-11-5-4-10-20(19)21)26(29)24-18-28(17-9-3-8-16-27)25-13-7-6-12-22(24)25/h4-7,10-15,18H,2-3,8-9,16-17H2,1H3 |
| InChIKey |
NSCXPXDWLZORPX-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
387.498 g/mol |
| Nominal Mass |
387 u |
| Quality |
944 |
| Retention Index |
3602 |
| SMILES |
C=1(C=2C(N(C1)CCCCCF)=CC=CC2)C(C=1C2=C(C(=CC1)CC)C=CC=C2)=O |
| SPLASH |
splash10-0gwu-2988000000-b07f5da74d386d2d7ebe |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
AM-2201 ET
EAM2201
(1-(5-Fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)methanone |
| Technique |
GC/MS |
| Wiley ID |
DD2024_019032 |
